Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen
Details
Publication Year 2023-08-21,Volume 14,Issue #1,Page 5063
Journal Title
Nature Communications
Abstract
Specificity remains a major challenge to current therapeutic strategies for cancer. Mutation associated neoantigens (MANAs) are products of genetic alterations, making them highly specific therapeutic targets. MANAs are HLA-presented (pHLA) peptides derived from intracellular mutant proteins that are otherwise inaccessible to antibody-based therapeutics. Here, we describe the cryo-EM structure of an antibody-MANA pHLA complex. Specifically, we determine a TCR mimic (TCRm) antibody bound to its MANA target, the KRAS(G12V) peptide presented by HLA-A*03:01. Hydrophobic residues appear to account for the specificity of the mutant G12V residue. We also determine the structure of the wild-type G12 peptide bound to HLA-A*03:01, using X-ray crystallography. Based on these structures, we perform screens to validate the key residues required for peptide specificity. These experiments led us to a model for discrimination between the mutant and the wild-type peptides presented on HLA-A*03:01 based exclusively on hydrophobic interactions.
Publisher
NPG
Keywords
*Proto-Oncogene Proteins p21(ras)/genetics; *Antibodies; Recognition, Psychology; Hydrophobic and Hydrophilic Interactions; HLA-A Antigens/genetics
Research Division(s)
Structural Biology
PubMed ID
37604828
Open Access at Publisher's Site
https://doi.org/10.1038/s41467-023-40821-w.
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2023-08-28 09:37:22
Last Modified: 2023-08-28 09:56:29
An error has occurred. This application may no longer respond until reloaded. Reload 🗙